Are you a media representative looking for content on Bayer? This section provides news, press photos and more.
News
June 05, 2026
Not intended for U.S. and UK Media – Late-Breaking data from pooled analysis INFINITY presented at 63rd ERA Congress:
Finerenone significantly reduced the risk of kidney disease progression and cardiovascular outcomes in broad patient populations with CKD
June 05, 2026
Not intended for U.S. and UK Media – Late-Breaking FIND-CKD results presented at 63rd ERA Congress 2026:
Bayer’s finerenone significantly reduced kidney function decline and a composite of cardiovascular-kidney outcomes versus placebo in patients with non-diabetic chronic kidney disease
May 22, 2026
Not intended for U.S. and UK Media
Kerendia™ approved in China for new indication in adult patients with heart failure with LVEF ≥40%
In Focus
Our Services
Publications
Get easy access to the different reports, magazines and brochures from Bayer.
Publikationen
Discover more
